From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ryan, Rajaee, Olson, Lesniak, Peiris); the Alberta Health Services Cross Cancer Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, Alta. (Ghosh).
From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ryan, Rajaee, Olson, Lesniak, Peiris); the Alberta Health Services Cross Cancer Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, Alta. (Ghosh)
Can J Surg. 2024 Nov 6;67(6):E363-E369. doi: 10.1503/cjs.004723. Print 2024 Nov-Dec.
Re-operation after breast-conserving surgery for invasive breast cancer is variable among centres and individual surgeons. In this study, we aimed to characterize the current landscape of practice regarding re-operation for invasive breast cancer in the province of Alberta.
This study was a retrospective review of the Synoptec database for patients undergoing primary breast-conserving surgery for invasive breast cancer or reoperation in the province of Alberta in the year 2020. We extracted data on demographic and tumour characteristics, use of intraoperative margin-assessment strategies, and surgical facility. We conducted univariate and multivariate logistic model analyses.
We included 1391 breast surgeries in the study. A total of 158 patients underwent re-operation during the study period. The median time to first reoperation was 34 days. The overall re-operation rate was 11.4% (range 5.4%-18.5%) among surgical facilities. The completion mastectomy rate was 5.2%, and 1.5% of patients underwent multiple revisional surgeries. Tumour multifocality was associated with increased revisional surgery rates on multivariate analysis (odds ratio 2.80).
The results of this study are consistent with the published literature. We have identified heterogeneity among sites in Alberta for revisional surgery after breast-conserving surgery for invasive breast cancer. This highlights an opportunity for ongoing education and quality improvement in breast cancer care in the province of Alberta.
保乳手术后再次手术治疗浸润性乳腺癌在各中心和外科医生之间存在差异。本研究旨在描述 2020 年艾伯塔省保乳手术后再次手术治疗浸润性乳腺癌的现状。
这是一项对 Synoptec 数据库的回顾性研究,纳入了 2020 年在艾伯塔省接受原发性保乳手术或再次手术治疗浸润性乳腺癌的患者。我们提取了人口统计学和肿瘤特征、术中切缘评估策略以及手术设施的相关数据。我们进行了单变量和多变量逻辑模型分析。
本研究共纳入 1391 例乳房手术。在研究期间,共有 158 例患者接受了再次手术。首次再次手术的中位时间为 34 天。各手术设施的总体再次手术率为 11.4%(范围 5.4%-18.5%)。完成乳房切除术的比例为 5.2%,1.5%的患者接受了多次修正手术。多灶性肿瘤与多变量分析中的修正手术率增加相关(比值比 2.80)。
本研究结果与已发表的文献一致。我们已经确定了艾伯塔省各站点在保乳手术后再次手术治疗浸润性乳腺癌方面存在异质性。这突出了在艾伯塔省乳腺癌治疗中持续开展教育和质量改进的机会。